-- 
Widemed Soars Most in Almost Two Months on U.S. FDA Approval

-- B y   G w e n   A c k e r m a n
-- 
2011-09-04T09:16:09Z

-- http://www.bloomberg.com/news/2011-09-04/widemed-soars-most-in-almost-two-months-on-u-s-fda-approval.html
Widemed (WDMD)  Ltd. soared the most in
almost two months after it said it got approval from the U.S.
Food & Drug Administration to market its Morpheus cardio-sleep
analysis system.  The shares rose as much 21 percent, their biggest jump
since July 10, to 0.734 shekels, and traded at 0.722 shekels as
of 12:15 p.m. in  Tel Aviv .  To contact the reporter on this story:
Gwen Ackerman in Tel Aviv at 
 gackerman@bloombeg.net   To contact the editor responsible for this story:
Claudia Maedler at   cmaedler@bloomberg.net  